Banking Stocks Are in the Spotlight after Fed’s Stress Tests

More Pressure On Deutsche Bank

It’s a gloomy morning at Deutsche Bank AG (USA) (NYSE:DB), as the German banking giant failed to pass the Fed’s stress tests for the second year in a row. Although Deutsche Bank showed some improvement compared to last year’s tests, the Fed still found weakness in the bank’s ability to manage data for risk management and capital planning. This has put even more pressure on the stock which was battered following UK’s vote on exiting the European Union. Deutsche Bank AG (USA) (NYSE:DB)’s shares plummeted by 21% since the vote results came out and are set to fall further today, currently down by 3.2% in pre-market trading. Only 10 of the funds in our database reported a long position in Deutsche Bank AG (USA) (NYSE:DB) in their latest 13F filings, up from nine registered a quarter earlier.

Banco Santander Also Failed

Banco Santander, S.A. (ADR) (NYSE:SAN)‘s US arm was also rebuked by the Federal Reserve, having failed the test for the third year in a row. Although regulators have the ability to impose harsher punishment for repeated failure, Fed officials have not commented on how they plan to react if the bank fails again next year. The management of Santander Holdings USA has accepted the verdict and promised to work on meeting the regulator’s expectations. “We are financially sound. These results do not affect our ability to serve our customers,” said Scott Powell, Chief Executive Officer of Santander Holdings USA. Having failed the test prevents Deutsche Bank and Banco Santander, S.A. (ADR) (NYSE:SAN) only from sending the profits back to their respective parent companies in Europe. And since neither of them have made this request, the Fed’s decision has no practical impact. Hedge fund sentiment towards Banco Santander, S.A. (ADR) (NYSE:SAN) was unchanged during the first quarter, with the number of long positions staying put at 17.

Morgan Stanley Passed But Only Just

Morgan Stanley (NYSE:MS) is the only US bank that managed to conditionally pass the Fed’s stress tests. The regulator was not happy with the bank’s capital planning and has ordered them to resubmit the adjusted documents by the end of the year. The Fed also noted that Morgan Stanley’s scenario for the simulated meltdown test failed to “adequately reflect the risks and vulnerabilities specific to the firm.” Still, the regulator gave the green light for an increase in dividends and stock buyback. Morgan Stanley (NYSE:MS) announced a 33% hike in its dividend to $0.20 per share and a 40% boost to its share repurchase program to $3.5 billion. The stock opened slightly higher this morning, but is still down by 17% year-to-date. At the end of March, 52 of the funds in our database reported a long position in Morgan Stanley (NYSE:MS), up from 50 registered at the end of December.

Disclosure: none